O60911 (CATL2_HUMAN) Homo sapiens (Human)
Cathepsin L2 UniProtKBProtein AtlasInterProSTRINGInteractive Modelling
334 aa; Sequence (Fasta)
Available Structures
25 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Tick salivary cystatin Ricistatin in complex with cathepsin V |
Heteromer A0A0K8RMA7; | 99.08 | 1×GOL; 6×EDO; 1×PEG; | |||
| Unreduced cathepsin V in complex with stefin A |
Heteromer P01040; | 99.09 | ||||
| Structure of clitocypin - cathepsin V complex |
Heteromer Q3Y9I6; | 99.09 | 1×SO4; | |||
| Peptide GAKSAA in complex with human cathepsin V C25A mutant | homo-2-mer | 98.65 | 5×MPD; 3×CL; 3×GOL; 1×TFA; | |||
| Sulfonated Calpeptin is a promising drug candidate against SARS-CoV-2 infections | homo-2-mer | 99.09 | 6×CL; 5×MPD; 6×GOL; 2×RN2; | |||
| Peptide VACKSSQP in complex with human cathepsin V C25A mutant | homo-2-mer | 98.64 | 6×MPD; 2×CL; 4×GOL; 1×TFA; | |||
| Peptide AYFKKVL in complex with human cathepsin V C25A mutant | homo-2-mer | 98.64 | 9×MPD; 2×CL; 6×GOL; 1×TFA; 2×NH2; | |||
| Peptide EVCKKKK in complex with human cathepsin V C25A mutant | homo-2-mer | 98.64 | 5×MPD; 1×CL; 2×GOL; 4×TFA; | |||
| Peptide VYEKKP in complex with human cathepsin V C25S mutant | monomer | 98.65 | 2×CL; 1×GOL; 2×TFA; 1×MPD; | |||
| Peptide KPKKKTK in complex with human cathepsin V C25A mutant | monomer | 98.65 | 2×MPD; 1×GOL; 4×TFA; | |||
| Peptide AVAEKQ in complex with human cathepsin V C25S mutant | monomer | 98.65 | 2×CL; 3×MPD; | |||
| Peptide IILKEK in complex with human cathepsin V C25S mutant | monomer | 98.65 | 2×GOL; | |||
| Peptide LLKVAL in complex with human cathepsin V C25S mutant | monomer | 98.65 | 1×CL; 2×MPD; 1×GOL; | |||
| Peptide VPCGTAHE in complex with human cathepsin V C25A mutant | monomer | 98.65 | 2×MPD; 1×CL; 2×GOL; | |||
| Peptide KKYDAFLA in complex with human cathepsin V C25A mutant | monomer | 98.65 | 1×CL; 2×MPD; | |||
| Peptide ALAASS in complex with human cathepsin V C25S mutant | monomer | 98.65 | 1×CL; 1×MPD; | |||
| Peptide GAKSAA in complex with human cathepsin V C25A mutant | monomer | 98.64 | 4×MPD; 7×GOL; 4×CL; 1×NA; | |||
| Peptide LLKAVAEKQ in complex with human cathepsin V C25A mutant | monomer | 98.64 | 3×CL; 3×MPD; 2×GOL; | |||
| Peptide GNYKEAKK in complex with human cathepsin V C25A mutant | monomer | 98.64 | 4×MPD; 1×CL; 1×TFA; 2×GOL; | |||
| CRYSTAL STRUCTURE OF HUMAN CATHEPSIN V COMPLEXED WITH AN IRREVERSIBLE VINYL SULFONE INHIBITOR | monomer | 99.09 | 1×0IW; 1×SO4; | |||
| Peptide LLKVAL in complex with human cathepsin V C25S mutant | monomer | 98.64 | 3×MPD; 2×GOL; | |||
| Peptide TRESEDLE in complex with human cathepsin V C25A mutant | monomer | 98.64 | 3×MPD; 2×CL; 2×GOL; | |||
| Peptide QLRQQE in complex with human cathepsin V C25A mutant | monomer | 98.64 | 2×CL; 1×MPD; 1×GOL; 1×TFA; | |||
| Peptide LLSGKE in complex with human cathepsin V C25S mutant | monomer | 98.64 | 2×CL; 1×MPD; | |||
| Peptide RLSAKP in complex with human cathepsin V C25S mutant | monomer | 98.64 | 2×MPD; 1×CL; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6jd0.1.A | monomer | 0.86 | 2×POL; | 77.32 | ||